![Orchard Therapeutics 355x200.jpg](https://www.bioindustry.org/static/derivatives/jobdetailscompanylogo_dd64811c02712599828cc4c462858531/405a86ee-e962-4223-994fb9690d8655a4.jpg)
Orchard Therapeutics (Europe) Limited
The company, incorporated in 2005 is dedicated to bringing transformative gene therapies to patients with serious and life-threatening orphan diseases.
Our programmes are using the potential of ex-vivo autologous haematopoietic stem cell gene therapy to restore normal gene function in severe and life-threatening inherited disorders.
We work in partnership with the world's leading research centres to harness the life-giving potential of gene therapy.
Our mission is to translate results from pre-clinical and early clinical research into commercially approved therapies for patients around the world.